Polyrizon Regains Compliance with Nasdaq Listing Requirements
Ra’anana, Israel, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (“Polyrizon” or the “Company”), a biotechnology company focusing on the development of intranasal products, toda...
How does the compliance status impact the company’s strategic growth plans and pipeline development?
What is the timeline for any potential secondary offerings or capital raises now that compliance is restored?
Are there any upcoming milestones or news releases that could further influence PLRZ’s stock performance?
10 days ago